Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.

Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Nov 2007

Loria P, Lonardo A, Bellentani S, Day C P, Marchesini G, Carulli N

Abstract excerpt

AIMS: To review available data concerning the basic science and epidemiological-clinical evidence for an association of NAFLD and cardiovascular disease. DATA SYNTHESIS: Non-alcoholic fatty liver disease (NAFLD) defines alcohol-like hepatic histological lesions seen in the non-alcoholic, insulin resistant patient representing the hepatic counterpart of the metabolic syndrome. Along with insulin resistance,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prevalence
Share to Atherosclerosis
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Comorbidity

Share to Disease Susceptibility

Share to Fatty Liver

Share to Metabolic Syndrome

Share to Risk Factors

Source

Identifiers

PMID: 17560098
DOI: 10.1016/j.numecd.2007.01.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.PMID 17560098Read ↗

[Pathogenesis of non-alcoholic fatty liver disease].Semantic proximity Read ↗

Non-alcoholic fatty liver disease pathogenesis: the present and the future.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.Semantic proximity Read ↗

Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.Semantic proximity Read ↗

The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Semantic proximity Read ↗

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.Semantic proximity Read ↗

Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside.Semantic proximity Read ↗

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.Semantic proximity Read ↗

Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin.Semantic proximity Read ↗

Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease.Semantic proximity Read ↗

From the metabolic syndrome to NAFLD or vice versa?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.